Immunome Inc (IMNM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Operating Expenses | 8,926 | 11,654 | 7,844 | 7,723 | 5,740 |
| Operating Income | -8,926 | -11,654 | -7,844 | -7,723 | -5,740 |
| Interest Expense | 0 | 0 | 8 | 3 | -1 |
| Other Income | 2 | 1 | -3 | 6 | 500 |
| Pre-tax Income | -8,924 | -11,653 | -7,855 | -7,720 | -5,239 |
| Net Income Continuous | -8,924 | -11,653 | -7,855 | -7,720 | -5,239 |
| Net Income | $-8,924 | $-11,653 | $-7,855 | $-7,720 | $-5,239 |
| EPS Basic Total Ops | -0.74 | -0.96 | -0.66 | -0.65 | -0.46 |
| EPS Basic Continuous Ops | -0.74 | -0.96 | -0.67 | -0.65 | -0.46 |
| EPS Diluted Total Ops | -0.74 | -0.96 | -0.66 | -0.65 | -0.46 |
| EPS Diluted Continuous Ops | -0.74 | -0.96 | -0.67 | -0.65 | -0.46 |
| EBITDA(a) | $-8,805 | $-11,518 | $-7,726 | $-7,437 | $-5,565 |